Al-Marsad newspaper: Oncologists in Britain have revealed a new cancer treatment that can stop the progression of the disease in patients who do not respond to immunotherapy.
Doctors found a treatment that could reverse the cancer’s resistance to immunotherapy, and they also found that patients expected to die after exhausting all treatment options lived longer, according to the Guardian website.
The combination of pembrolizumab, an immunotherapy drug, and guadcitabine, a new generation of DNA methylating factor, halted the progression of cancer in more than a third of patients enrolled in the first phase of the trial.
As experts at the Institute of Cancer Research explained, the dual mixture could become a new effective weapon against many forms of cancer.
Immunotherapy uses the immune system to target and kill cancer cells, and can save lives when other treatment options, such as surgery, radiotherapy or chemotherapy, fail.